NEW Study Released About the COVID-19 PILL From MERCK: Molnupiravir - What you NEED to KNOW

Due to their recent findings, Merck and partner Ridgeback Biotherapeutics asked the U.S. Food and Drug Administration to grant emergency use authorization for their new drug, Molnupiravir, to treat adults with mild-to-moderate COVID-19 who are at risk for severe disease or hospitalization. 

In today's episode, I use my biochemistry background along with my many years of experience in the medical field to dissect their study, what it could mean for the future of the Coronavirus Pandemic and explain just how Molnupiravir works. Is the COVID-19 pill a replacement to the mRNA vaccines? Is their a risk of Molnupiravir affecting your own DNA? Could this pill dramatically reduce the deaths from COVID-19? I go over all of these questions and more.  

Links to the resources I discuss in this episode:

Merck and Ridgeback’s Investigational Oral Antiviral Molnupiravir Reduced the Risk of Hospitalization or Death by Approximately 50 Percent Compared to Placebo for Patients with Mild or Moderate COVID-19 in Positive Interim Analysis of Phase 3 Study:
https://www.merck.com/news/merck-and-ridgebacks-investigational-oral-antiviral-molnupiravir-reduced-the-risk-of-hospitalization-or-death-by-approximately-50-percent-compared-to-placebo-for-patients-with-mild-or-moderat/

β-D-N4-hydroxycytidine Inhibits SARS-CoV-2 Through Lethal Mutagenesis But Is Also Mutagenic To Mammalian Cells:
https://academic.oup.com/jid/article/224/3/415/6272009?login=true

Letter to the Editor in Response to Zhou et al:
https://academic.oup.com/jid/advance-article/doi/10.1093/infdis/jiab362/6319402

Thank you for joining me on another episode of Baktari MD! Do you have a question regarding our healthcare system? Please leave your question in the comments below so I can make an episode about it. Also, I’d love to hear any suggestions you may have for future content.

For more information, please visit: https://jonathanbaktarimd.com/
Sign up for my newsletter here: https://ns.jonathanbaktarimd.com/

SOCIAL:
Facebook: https://www.facebook.com/baktarimd
Instagram: https://www.instagram.com/baktarimd/
Twitter: https://twitter.com/BaktariMD
LinkedIn: https://www.linkedin.com/in/jonathan-baktarimd/

YouTube: https://www.youtube.com/baktarimd

Disclaimer: All information discussed or provided by Jonathan Baktari, M.D. (“Dr. Baktari”) and/or his affiliates/guests are for educational purposes only. The information discussed and provided is not a substitute for professional medical advice, diagnosis, or treatment.  Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical concern or condition. Never disregard professional medical advice or delay in seeking it because of any information discussed or provided by Dr. Baktari or his affiliates/guests!  If you think you may have a medical emergency, call 911 immediately.  All information concerning hospitals, physicians, insurers, and other healthcare-related companies is based on Dr. Baktari’s observations of the healthcare industry as a whole and do not reflect on any specific hospital, physician, insurer, or other healthcare-related company.